These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28031371)

  • 1. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
    Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer.
    Chen KY; Santos Afonso ED; Enouf V; Isel C; Naffakh N
    PLoS Pathog; 2019 Oct; 15(10):e1008034. PubMed ID: 31581279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
    Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
    Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
    Zhou Z; Liu T; Zhang J; Zhan P; Liu X
    Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
    Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
    FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
    Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
    Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling.
    Trist IM; Nannetti G; Tintori C; Fallacara AL; Deodato D; Mercorelli B; Palù G; Wijtmans M; Gospodova T; Edink E; Verheij M; de Esch I; Viteva L; Loregian A; Botta M
    J Med Chem; 2016 Mar; 59(6):2688-703. PubMed ID: 26924568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
    Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening.
    Liu M; Lo CY; Wang G; Chow HF; Ngo JC; Wan DC; Poon LL; Shaw PC
    Antiviral Res; 2017 Aug; 144():186-195. PubMed ID: 28629986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
    Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
    Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.
    Reuther P; Mänz B; Brunotte L; Schwemmle M; Wunderlich K
    J Virol; 2011 Dec; 85(24):13298-309. PubMed ID: 21957294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.
    Zhang J; Hu Y; Musharrafieh R; Yin H; Wang J
    Curr Med Chem; 2019; 26(13):2243-2263. PubMed ID: 29984646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.
    Massari S; Nannetti G; Desantis J; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Palù G; Cruciani G; Loregian A; Goracci L; Tabarrini O
    J Med Chem; 2015 May; 58(9):3830-42. PubMed ID: 25856229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus.
    Kessler U; Castagnolo D; Pagano M; Deodato D; Bernardini M; Pilger B; Ranadheera C; Botta M
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5575-7. PubMed ID: 24012120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
    Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
    Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
    Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of intracellular nanobodies targeting the influenza virus RNA-polymerase core.
    Bessonne M; Morel J; Nevers Q; Da Costa B; Ballandras-Colas A; Chenavier F; Grange M; Roussel A; Crépin T; Delmas B
    PLoS Pathog; 2024 Jun; 20(6):e1011642. PubMed ID: 38875296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase.
    Chan CP; Yuen CK; Cheung PH; Fung SY; Lui PY; Chen H; Kok KH; Jin DY
    FASEB J; 2018 Aug; 32(8):4380-4393. PubMed ID: 29513570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-IInterferon-Inducible SERTAD3 Inhibits Influenza A Virus Replication by Blocking the Assembly of Viral RNA Polymerase Complex.
    Sun N; Li C; Li XF; Deng YQ; Jiang T; Zhang NN; Zu S; Zhang RR; Li L; Chen X; Liu P; Gold S; Lu N; Du P; Wang J; Qin CF; Cheng G
    Cell Rep; 2020 Nov; 33(5):108342. PubMed ID: 33147462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits.
    Naito T; Momose F; Kawaguchi A; Nagata K
    J Virol; 2007 Feb; 81(3):1339-49. PubMed ID: 17121807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.